Review
Open access
Jul 2026
Modeling myeloid cell development in health and disease using induced pluripotent stem cells
Key applications of iPSC technology in hemato-oncology are summarized, its major advantages and current limitations are discussed, and emerging directions are highlighted, including scalable iPSC-derived blood cell therapies for inherited and acquired bone marrow failure syndromes and leukemia.
Ivan Tesakov, M. Nasri, M. Klimiankou et al.
· Frontiers in Immunology · 0 citations